Clinical Trial Update: Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects [NA]

View source ↗

Summary

Clinical trial update for a study assessing sample quality for cell-mediated immunity in ART-naïve HIV-1-infected subjects; study status completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GlaxoSmithKline

Snippet

Sponsor: GlaxoSmithKline | Conditions: AIDS, AIDS Vaccines | NA | Status: COMPLETED | Results posted: 2020-04-24